Application NotesApplication of High Performance Time-of-Flight Mass Spectrometry to the Non-Targeted Detection of Illicit Drugs of Abuse in Urine
Application NotesHigh-Throughput Confirmation and Quantitation of a THC Metabolite in Urine Using Single Quadrupole GC/MS
Application NotesQuantification of Steroids and 25-OH Vitamin D3 in Dried Blood Spots and Serum using LC/MS/MS
Application NotesQuantification of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Biological Samples by LC/MS/MS
Application NotesSimultaneous Quantitative Determination of Ethyl Glucuronide and Ethyl Sulphate in Human Urine using UPLC®/MS/MS
Application NotesLC/MS/MS Analysis of Metabolites of Synthetic Cannabinoids JWH-018 and JWH-073 in Urine
Application NotesMaking the Leap to LC/MS/MS: Enhancing and Accelerating Clinical Research and Forensic Toxicology Applications
Application NotesQuantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer
Application NotesLC-MS/MS Method Development for Buprenorphine, Norbuprenorphine, Propoxyphene and Norpropoxyphene Analysis in Human Urine
Application NotesA Screening Method for Major Metabolites of JWH-018 and JWH-073 in Human Urine Using a QTRAP System
Application NotesAutomated Solid Phase Extraction of THC and Metabolites from Whole Blood using the Gilson GX‐274 ASPEC™
Application NotesAutomated Solid Phase Extraction of Benzodiazepines from Urine using the Gilson GX‐274 ASPEC™
Application NotesCharacterization of Two Wastewaters for Explosives using On-Column Injection and GC-TOFMS
Application NotesQuantitation of 12 Benzodiazepines and Metabolites in Urine Using Ultrahigh Resolution LC-MS for Forensic Toxicology Use
